These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32207718)

  • 1. [Combination of central and peripheral muscle relaxants in the treatment of post-stroke spasticity].
    Iskra DA; Kovalenko AP; Koshkarev MA; Frunza DN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):51-57. PubMed ID: 32207718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intrathecal baclofen on muscle co-contraction in children with spasticity of cerebral origin.
    Sgouros S; Seri S
    Pediatr Neurosurg; 2002 Nov; 37(5):225-30. PubMed ID: 12411712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal baclofen for spasticity caused by thrombotic stroke.
    Gwartz BL
    Am J Phys Med Rehabil; 2001 May; 80(5):383-7. PubMed ID: 11327562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of intrathecal baclofen in the treatment of spasticity in stroke].
    Lamotte D; Cantalloube S
    Ann Readapt Med Phys; 2007 Apr; 50(3):165-9. PubMed ID: 17145092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience in using xeomin in the treatment of arm and hand spasticity in the early rehabilitation phase of stroke].
    Kostenko EV; Petrova LV; Ganzhula PA; Lisenker LN; Otcheskaia OV; Khozova AA; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2):29-34. PubMed ID: 22677662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum toxin in treatment of lower limb spasticity in patients with brain damage].
    Kovalenko AP; Misikov VK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):28-34. PubMed ID: 30335069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial.
    Bresolin N; Zucca C; Pecori A
    Adv Ther; 2009 May; 26(5):563-73. PubMed ID: 19458926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative effectiveness of different muscle relaxants in the rehabilitation of post-stroke patients with spasticity].
    Lipták J
    Ideggyogy Sz; 2013 Nov; 66(11-12):429. PubMed ID: 24555245
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS).
    Creamer M; Cloud G; Kossmehl P; Yochelson M; Francisco GE; Ward AB; Wissel J; Zampolini M; Abouihia A; Berthuy N; Calabrese A; Loven M; Saltuari L
    J Neurol Neurosurg Psychiatry; 2018 Jun; 89(6):642-650. PubMed ID: 29326296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy].
    Kurenkov AL; Klochkova OA; Bursagova BI; Karimova HM; Kuzenkova LM; Mamedyarov AM; Namazova-Baranova LS; Agranovich OV; Agranovich AO; Soboleva OA; Khapaeva MM; Batysheva TT; Sarzhina MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):37-44. PubMed ID: 29265085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum neurotoxin-A in a patient with post-stroke spasticity: a neurophysiological study.
    Fawzi SM; Hamdan FB; Jaafar IF; Gawwam GAASA
    Folia Neuropathol; 2023; 61(4):412-418. PubMed ID: 38174669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacology of spasticity. Does therapy remain in deep sleep?].
    Noth J
    Nervenarzt; 2000 Dec; 71(12):927-8. PubMed ID: 11139987
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
    Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
    Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The underutilization of intrathecal baclofen in poststroke spasticity.
    Dvorak EM; Ketchum NC; McGuire JR
    Top Stroke Rehabil; 2011; 18(3):195-202. PubMed ID: 21642057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of therapeutic response to baclofen vs tolperisone in spasticity.
    Agarwal S; Patel T; Shah N; Patel BM
    Biomed Pharmacother; 2017 Mar; 87():628-635. PubMed ID: 28086137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Intrathecal Baclofen on Pain and Quality of Life in Poststroke Spasticity.
    Creamer M; Cloud G; Kossmehl P; Yochelson M; Francisco GE; Ward AB; Wissel J; Zampolini M; Abouihia A; Calabrese A; Saltuari L
    Stroke; 2018 Sep; 49(9):2129-2137. PubMed ID: 30354975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged anti-spasticity effects of bolus intrathecal baclofen.
    Baguley IJ; Bailey KM; Slewa-Younan S
    Brain Inj; 2005 Jul; 19(7):545-8. PubMed ID: 16134742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcutaneous electrical nerve stimulation versus baclofen in spasticity: clinical and electrophysiologic comparison.
    Aydin G; Tomruk S; Keleş I; Demir SO; Orkun S
    Am J Phys Med Rehabil; 2005 Aug; 84(8):584-92. PubMed ID: 16034227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Scales and tests in the rehabilitation and treatment of patients with spasticity of the upper limbs].
    Kovalenko AP; Kamaeva OV; Poleshchuk YR; Kovlen DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(4):107-114. PubMed ID: 32490627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity.
    Kanovský P; Slawek J; Denes Z; Platz T; Sassin I; Comes G; Grafe S
    Clin Neuropharmacol; 2009; 32(5):259-65. PubMed ID: 19644361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.